We are thrilled to announce that Dr. Indu S. Javeri, President and CEO of CuriRx, Inc., has joined the Advisory Board of PurCell Bio.

Dr. Javeri holds a Ph.D. in Chemistry from the University of Oklahoma and has a rich background in the biotechnology and pharmaceutical industries. As the head of CuriRx, a Contract Research, Development, and Manufacturing Company (CRDMO), she has successfully led collaborations with various companies, contributing to the development of a diverse range of products, including biologics, viral and non-viral vectors, small molecules, peptides, proteins, vaccines, generics, and biosimilars.

CuriRx, under Dr. Javeri’s leadership, is committed to fostering a healthy and collaborative work environment. The company places a strong emphasis on shared values, prioritizing individual growth, client relationships, contributions to the scientific community, and, ultimately, patient well-being.

Science & Technology Collaboration:

ARM provides a platform for PurCell Bio to collaborate with industry experts, sharing and improving innovative approaches to process development, manufacturing, control, and distribution of cell and gene medicines.

Extensive Networking Opportunities

Membership in ARM facilitates connections with commercial leaders, potential partners, patient advocacy groups, and research institutions through participation in ARM events, Advisory Groups, Forums, and Working Groups.

Capital Formation Exposure:

PurCell Bio gains exposure to the international investment community through ARM events, presentation opportunities, and the extensive ARM network.

Access to ARM Events and Industry Information:

ARM membership offers access to exclusive speaking opportunities, special rates for ARM and other industry events, and the most current industry data, including financings, partnerships, clinical trials, and key regulatory and policy changes.

Increased Visibility and Engagement:

PurCell Bio can showcase its accomplishments, priorities, and opportunities to a diverse multi-stakeholder audience at various ARM events throughout the year.